Compounds > uric acid

uric acid and clopidogrel

uric acid has been researched along with clopidogrel in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's6 (66.67)24.3611
2020's3 (33.33)2.80

Authors

AuthorsStudies
Chrzczanowicz, J; Drygas, W; Gawron-Skarbek, A; Jegier, A; Kostka, J; Kostka, T; Nowak, D1
Barbieri, L; Bellomo, G; De Luca, G; Marino, P; Nardin, M; Pergolini, P; Rolla, R; Suryapranata, H; Verdoia, M1
Barbieri, L; Bellomo, G; De Luca, G; Marino, P; Nardin, M; Pergolini, P; Rolla, R; Schaffer, A; Suryapranata, H; Verdoia, M1
Cai, GY; Chen, XM; Duan, SW; Huang, W; Jia, Q; Li, JJ; Li, WG; Li, XM; Liu, SW; Liu, WH; Lun, LD; Ma, L; Sun, XF; Wang, YP; Wu, H; Wu, J; Xie, YS; Zhang, JR; Zhou, CH1
Baber, M; HamidAkash, MS; Hussain, SB; Irfan, M; Qadir, MI; Rehman, A1
Ashcroft, JA1
Gremmel, T; Hoberstorfer, T; Kopp, CW; Lee, S; Panzer, S; Pultar, J; Wadowski, PP; Weikert, C1
Abdus, S; Gong, X; Gu, Q; Li, C; Shi, L; Tan, C; Wang, G; Wang, J; Yang, M1
Chen, L; Li, J; Shi, X; Su, J; Yang, J; Yu, Q; Zhu, K1

Trials

1 trial(s) available for uric acid and clopidogrel

ArticleYear
Efficacy of Leflunomide, Telmisartan, and Clopidogrel for Immunoglobulin A Nephropathy: A Randomized Controlled Trial.
    Chinese medical journal, 2016, Aug-20, Volume: 129, Issue:16

    Topics: Adolescent; Adult; Benzimidazoles; Benzoates; Blood Pressure; China; Clopidogrel; Creatinine; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Isoxazoles; Kidney Function Tests; Leflunomide; Male; Middle Aged; Prospective Studies; Telmisartan; Ticlopidine; Treatment Outcome; Uric Acid; Young Adult

2016

Other Studies

8 other study(ies) available for uric acid and clopidogrel

ArticleYear
Factors determining the total serum antioxidant capacity in men with coronary heart disease--the powerful effect of treatment with thienopyridines.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2014, Volume: 24, Issue:6

    Topics: Adult; Aged; Antioxidants; Biomarkers; Cardiotonic Agents; Clopidogrel; Coronary Disease; Drug Therapy, Combination; Humans; Male; Middle Aged; Oxidative Stress; Thienopyridines; Ticlopidine; Uric Acid

2014
Uric acid and high-residual platelet reactivity in patients treated with clopidogrel or ticagrelor.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2016, Volume: 26, Issue:4

    Topics: Adenosine; Aged; Aged, 80 and over; Blood Platelets; Clopidogrel; Coronary Artery Disease; Female; Fibrinogen; Humans; Male; Middle Aged; Multivariate Analysis; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Factors; Ticagrelor; Ticlopidine; Triglycerides; Uric Acid

2016
Serum uric acid levels during dual antiplatelet therapy with ticagrelor or clopidogrel: Results from a single-centre study.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2016, Volume: 26, Issue:7

    Topics: Acute Coronary Syndrome; Adenosine; Aged; Aspirin; Biomarkers; Chi-Square Distribution; Clopidogrel; Coronary Artery Disease; Drug Therapy, Combination; Female; Humans; Logistic Models; Male; Middle Aged; Multivariate Analysis; Odds Ratio; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Risk Factors; Ticagrelor; Ticlopidine; Time Factors; Treatment Outcome; Up-Regulation; Uric Acid

2016
Short Communication: Evaluation of nephrotoxicity by aspirin-clopidogrel combination therapy in patients with acute coronary syndrome.
    Pakistan journal of pharmaceutical sciences, 2016, Volume: 29, Issue:6

    Topics: Acute Coronary Syndrome; Aspirin; Biomarkers; Blood Urea Nitrogen; Clopidogrel; Creatinine; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Kidney; Kidney Diseases; Platelet Aggregation Inhibitors; Risk Assessment; Ticlopidine; Time Factors; Treatment Outcome; Uric Acid

2016
Alternatives to specific uric acid lowering treatment in gout in patients with cardiovascular disease.
    BMJ (Clinical research ed.), 2018, Sep-20, Volume: 362

    Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Atorvastatin; Calcium Channel Blockers; Cardiovascular Diseases; Clopidogrel; Gout; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Losartan; Purinergic P2Y Receptor Antagonists; Risk Factors; Uric Acid

2018
Decreased Platelet Inhibition by Thienopyridines in Hyperuricemia.
    Cardiovascular drugs and therapy, 2021, Volume: 35, Issue:1

    Topics: Acute Coronary Syndrome; Adenosine Diphosphate; Aged; Angioplasty; Clopidogrel; Comorbidity; Cytochrome P-450 CYP2C9; Female; Genotype; Humans; Hyperuricemia; Male; Middle Aged; Platelet Activation; Platelet Aggregation Inhibitors; Prospective Studies; Purinergic P2Y Receptor Antagonists; Stents; Thienopyridines; Ticagrelor; Ticlopidine; Uric Acid

2021
Serum uric acid level negatively correlated with the prevalence of clopidogrel low response in patients undergoing antiplatelet treatment with aspirin and clopidogrel.
    Nutrition, metabolism, and cardiovascular diseases : NMCD, 2020, 11-27, Volume: 30, Issue:12

    Topics: Aged; Aged, 80 and over; Aspirin; Biomarkers; Clopidogrel; Coronary Artery Disease; Cross-Sectional Studies; Drug Resistance; Dual Anti-Platelet Therapy; Female; Humans; Male; Middle Aged; Percutaneous Coronary Intervention; Platelet Aggregation; Platelet Aggregation Inhibitors; Risk Assessment; Risk Factors; Treatment Outcome; Up-Regulation; Uric Acid

2020
The DNAm levels of CREB5 (cg11301281) were associated with clopidogrel resistance.
    Journal of clinical laboratory analysis, 2022, Volume: 36, Issue:10

    Topics: Acute Coronary Syndrome; Albumins; Blood Platelets; Clopidogrel; Cyclic AMP Response Element-Binding Protein A; Glycated Hemoglobin; Humans; Platelet Aggregation Inhibitors; RNA, Messenger; Ticlopidine; Uric Acid

2022